Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma.
Freeman
Bradley
B
University of South Florida College of Medicine, Tampa, FL, USA.
Levy
Woodburne
W
Gorman
Jack M
JM
D000284:Administration, Oral; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068180:Aripiprazole; D000077465:Cabergoline; D002998:Clonazepam / Q000009:adverse effects / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D010348:Patient Care Team; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D011388:Prolactin / Q000097:blood; D015175:Prolactinoma / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000097:blood / Q000150:complications* / Q000188:drug therapy*
D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D004873:Ergolines; D010879:Piperazines; D015363:Quinolones; D002998:Clonazepam; D000068180:Aripiprazole; D011388:Prolactin; D000077465:Cabergoline